pAd1129-27 is a shuttle plasmid designed for constructing adenovirus vectors characterized by a 2.7 kb deletion in the E3 region, and a hybrid Ad5/3 fiber. A 2.7 kb BglII fragment including E3 6.7K, gp19K membrane protein, the adenovirus “death” protein ADP, RID-a, RID-ß, and14.7K was deleted, and replaced with a multiple cloning site. The E3 12.5K ORF is truncated. The U exon is intact. The Ad5/3 hybrid fiber is made of the N-terminal tail and shaft of Ad5 fused to the knob of Ad3.

pAd1129-27 can be used to construct replication-deficient or oncolytic adenovirus vectors expressing large transgenes (inserted into the E3 region itself or elsewhere), or multiple expression cassettes (for instance two independent expression cassettes, one in the E1 region, and the other in the E3 region). Expression cassettes inserted into the E3 region should contain a promoter and poly(A) signal, but no intron nor splice site. The adenovirus sequences present in pAd1129-27 are flanked by two SfiI sites, which generate non-symmetrical sticky ends suitable for directional cloning with the other AdenoQuick2.0 plasmids (pAd1127, pAd1128, pAd1130, and their derivatives).

A cosmid is a large plasmid that was generated by infecting E. coli with bacteriophage lambda. Cosmids are really great tools to construct recombinant adenoviruses because their minimum sizes (~39 kb) accommodates the 36 kb adenovirus genomes almost perfectly. When you construct a recombinant adenovirus genome in E. coli using cosmid technology, you are almost sure that every colony carries a full-size genome, and not a smaller plasmid that lost chuncks of the adenovirus genome by DNA recombination.

Both PacI and SwaI are rare-cutting restriction enzymes that recognize 8 bp-sequences. Both of them are flanking both ends of the recombinant adenovirus genome contained in your cosmid. You should make sure that the enzyme that you will use to linearize your cosmid does not cut inside your transgene. If neither PacI nor SwaI cuts inside your transgene, there is really no preference. Because the PacI site is immediately flanking the start of the adenovirus genome, the DNA ends generated by PacI resemble the most the ends obtained from deproteinised virion DNA and might therefore be more efficient in promoting virus replication. In practice however, no difference in the time needed to recover the virus after DNA transfection into 293 cells is observed between both settings. Virus plaques can appear as early as 4 days after transfecting PacI- or SwaI-digested DNA into 293 cells.

In the adenovirus replication cycle, the expression of the E3 region helps the virus evading the host immune system. This region is not essential for virus replication in vitro and therefore can be deleted in order to construct adenoviruses containing longer transgenes, up to 7.7 kb.

Therefore, if you are using the most common 3.2 kb E1 deletion, and:

if your expression cassette (= promoter + coding sequence + polyA signal) is smaller than 5.0 kb, you can use adenovirus vectors with either wild-type or deleted E3 region.

if your expression cassette is larger than 5.0 kb but smaller than 7.7 kb, you must use E1/E3 deleted vectors.

if your expression cassette is larger than 7.7 kb, you must consider E1/E3/E4-deleted adenovirus vectors.

Notes:

In some applications such as oncolytic adenovirus vectors (CRAds), it might be desirable to retain the entire E3 region, or increase the expression of some E3 products: for instance, the adenovirus “death protein” E3-11.6K, which facilitates the release of viral particles from infected cells, or gp19K, whose constitutive expression reduces the host cytotoxic T cell response against the vector and increases the persistence of transgene expression on its own but possibly not in the context of constitutive expression of the entire E3 region.

The E3 region can also be used as a location to insert a second transgene, independent from the one inserted in the E1 region.

Yes, you can! When you digest your shuttle plasmid with SfiI, you will have to purify two SfiI fragments (instead of one). As a result, the ligation reaction that you will set up to construct your cosmid will contain 5 DNA fragments (instead of 4). The cloning efficiency will maybe decrease, but it will work, we have done it. You might have to verify the integrity of your cosmid with additional restriction digestions, or even sequencing, especially if the additional SfiI site is located inside the coding sequence of your transgene.

Our AdenoQuick2.0 system is very versatile. It allows for mutating practically every region of the Ad5 genome as long as the virus is viable and it is acceptable from safety and bioethics points of view. For instance you can mutate easily the E1a and E1b genes (e.g. ∆E1ACR2, ∆E1B19k), delete specific E3 genes (e.g. E3b gp19K) and replace them with transgenes so they become activated when the virus replicates, retarget the fiber to specific receptors, mutate the E4 ORFs, etc...

Not at all. The Cosmid Construction Kits -1 and -2 are shipped on dry ice because of the lambda packaging extract. The SfiI enzyme that is included in the kit will be frozen. We have verified experimentally that a single freeze/thaw cycle will not affect SfiI activity. However, avoid repeated freeze/thaw. Once you receive the enzyme, store it at -20 ºC.

For the AdenoQuick1.0 system, the current maximum cargo capacity is achieved with E1/E3/E4-deleted pAd362. The vector allows for inserting 8.9 kb foreign DNA into the E1 region.

For the AdenoQuick2.0 system, adenovirus vectors can be constructed, in which up to 11.2 kb foreign DNA can be inserted. It is done by combining the largest E1 deletion (3157 bp in shuttle plasmid pAd1127-02) with the largest E3 deletion and the hybrid Ad5/35 fiber ( 2686 bp + 756 bp in pAd1129-06), and the largest E4 deletion (2815 bp in shuttle plasmid pAd1130-03), plus the extra 1.8 kb that adenovirus capsids can accomodate in addition to the WT 36 kb genome (Bett et al, 1993. J. Virol. 67: 5911-21).

For the AdenoZAP system, the current maximum cargo capacity of 9.6 kb is obtained with AdenoZAP1.4.

The National Institute of Health has designated adenovirus as Level 2 biological agent. For most applications, working with adenovirus requires therefore a Biosafety Level 2 (BL2) facility. The NIH guidelines for research involving recombinant DNA molecules stipulate also that experiments which are likely to either enhance the pathogenicity (e.g. insertion of a host oncogene) or to extend the host range (e.g. introduction of novel control elements) of viral vectors under conditions that permit a productive infection should be performed in BL3 facilities.

A BL2 laboratory should contain:

A warning sign on the entrance door limiting the access to authorized persons only. The sign should identify the agent, list the name and phone number of the lab director or other responsible person, and indicate any special requirement for entering the lab.

A Class II biological safety cabinet. A Class II cabinet is a ventilated cabinet for personnel and product protection having an open front with inward airflow for personnel protection, and a HEPA filtered mass recirculated air flow for product protection. The face velocity of the inward flow of air through the full-width open front is 75 feet per minute or greater.

At least one tissue culture incubator dedicated to infected cell cultures. Another separate incubator is desirable for growing uninfected cells.

The minimal equipment to handle adenovirus culture without exiting the BL2 lab (such as centrifuges, microscope…).

A sink for hand washing

A chemical disinfectant kit or at least a gallon of bleach available for spills

Always wear a lab coat while in the virus lab. Before exiting the laboratory for non-laboratory areas (e.g. cafeteria, library, administrative offices…), remove your lab coat and leave it in the laboratory.

Avoid skin contamination with the virus. Always wear gloves (one pair OK, two pairs better for added protection). Once your gloves have been in contact with infectious material, do not touch common appliances such as telephone or doors handles. Change your gloves frequently.

Keep the lab doors closed while work is in progress.

Use mechanical pipetting devices. Do not pipet by mouth.

Decontaminate all work surfaces after you finish your work, and immediately after any spill. Spray a 10% bleach solution, wipe and spray again a 70% ethanol solution. For large liquid spills, add directly concentrated bleach to the liquid, leave for at least 5 minutes, and wipe.

Perform all procedures with infectious particles in the biosafety cabinet to minimize the exposure of personnel to aerosols. Minimize the creation of aerosols by pipetting virus cultures and suspension very gently. Use aerosol-resistant tips for pipetting virus suspensions. Do not conduct work with infectious materials in open vessels on the open bench.

Use needle-locking syringes or disposable syringe-needle units for the injection or aspiration of infectious fluids. Extreme care should be used to avoid auto-inoculation and aerosol generation. Needles should not be bent, sheared, replaced in their sheath or guard or removed from the syringe following use. The needle and syringe should be decontaminated by pipetting in and out concentrated bleach a few times and then promptly placed in a puncture-resistant container.

Decontaminate all contaminated liquid or solid wastes before disposal. Before starting your virus work, pour some bleach into a beaker. Rinse all materials (tissue culture dishes, pipets, tips…) that came into contact with adenovirus with 10% bleach inside the hood before discarding them in the Biohazard trash and autoclaving. Place all materials to be decontaminated off-site in a durable leakproof container which is closed before removal. If possible, leave the contaminated materials in contact with bleach for a few hours before autoclaving (e.g. after rinsing your pipets with concentrated bleach inside the hood, soak them in a cylinder containing 10% bleach before autoclaving).

Do not leave the BL2 laboratory with live viruses, unless they are in a sealed tube. Cell cultures transduced with adenoviruses should be inactivated either chemically or biochemically before leaving the BL2 facility.